FOLD — AMICUS THERAPEUTICS INC

Ownership history in Birchview Capital, LP  ·  34 quarters on record

This page tracks every 13F SEC filing in which Birchview Capital, LP reported a position in AMICUS THERAPEUTICS INC (FOLD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.11% (2025 Q4)
Avg. % of fund
0.36%
First filed
2017 Q3
Last filed
2025 Q4
Quarters held
34
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 253,000 — 0% 2.11% $3.6M $14.24
2025 Q3 ADDED 253,000 +225,000 +803.6% 1.51% $2.0M $7.88
2025 Q2 UNCHANGED 28,000 — 0% 0.16% $160K $5.73
2025 Q1 UNCHANGED 28,000 — 0% 0.20% $228K $8.16
30 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    FOLD price (monthly, adj. close)

Other funds also holding FOLD

As of 2025 Q4 — sorted by position size

Palo Alto Investors LP 3Y 7Y 10.32% Sand Grove Capital Management LLP 3Y 7Y 7.95% PSquared Asset Management AG 3Y 7Y 6.99% CM Management, LLC 3Y 4.44% Prosight Management, LP 3Y 7Y 3.38% KRYGER CAPITAL Ltd 3Y 3.29% Athos Capital Ltd 3Y 7Y 3.27% Chicago Capital Management, LLC 3Y 7Y 2.92% Bellevue Group AG 3Y 7Y 2.9% RICE HALL JAMES & ASSOCIATES, LLC 3Y 7Y 2.75%
← Back to Birchview Capital, LP Holdings